300233 金城醫藥
按盤價 
13.120 -0.200 (-1.502%)
13.120 -0.200 (-1.502%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 4.075 | 4.772 | 7.808 | 3.161 | -13.030 |
| 總資產報酬率 ROA (%) | 2.622 | 2.976 | 4.925 | 2.102 | -9.230 |
| 投入資產回報率 ROIC (%) | 3.247 | 3.773 | 6.180 | 2.558 | -10.935 | 邊際利潤分析 |
| 銷售毛利率 (%) | 40.132 | 43.727 | 46.223 | 52.616 | 58.120 |
| 營業利潤率 (%) | 7.763 | 6.383 | 10.091 | 6.693 | -14.005 |
| 息稅前利潤/營業總收入 (%) | 7.892 | 6.661 | 10.288 | 7.078 | -13.427 |
| 淨利潤/營業總收入 (%) | 6.445 | 5.463 | 8.155 | 3.922 | -16.229 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 92.470 | 108.534 | 107.602 | 111.833 | -77.231 |
| 價值變動淨收益/利潤總額(%) | -0.929 | 0.226 | 0.856 | 5.785 | -0.480 |
| 營業外收支淨額/利潤總額(%) | 0.851 | -0.196 | -2.258 | -6.868 | 2.484 | 償債能力分析 |
| 流動比率 (X) | 1.651 | 1.480 | 1.357 | 1.510 | 1.934 |
| 速動比率 (X) | 1.203 | 1.167 | 1.016 | 1.234 | 1.687 |
| 資產負債率 (%) | 32.868 | 36.088 | 37.192 | 34.800 | 0.307 |
| 帶息債務/全部投入資本 (%) | 15.777 | 16.791 | 16.826 | 15.680 | 14.386 |
| 股東權益/帶息債務 (%) | 508.298 | 471.687 | 469.060 | 506.267 | 573.681 |
| 股東權益/負債合計 (%) | 200.862 | 173.962 | 166.483 | 184.911 | 224.292 |
| 利息保障倍數 (X) | 127.405 | 22.930 | 24.528 | 8.681 | -14.373 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 58.459 | 60.464 | 60.513 | 74.018 | 85.594 |
| 存貨周轉天數 (天) | 98.727 | 97.678 | 92.665 | 81.750 | 77.773 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 18/11/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
